The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...
A majority of people with overweight or obesity prescribed glucagon-like peptide 1 receptor agonists (GLP-1 RAs) discontinue them within 1 year, with higher quit rates among those without type 2 ...
Share on Pinterest An increasing number of people without diabetes are using GLP-1 agonist drugs for weight loss only. Image credit: MarkHatfield/Getty Images. The last few years have seen a marked ...
If I have one recurring thought leading up to the holidays, it's got to be me looking through my shopping tabs and wondering, "Do I really need this?" And when I'm feeling more generous, "Is this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback